Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for November 2021

Shelley Wood

November 30, 2021

News Daily News

TAVI Is Broadening the Treatable AS Population, Not Cutting Into SAVR

Todd Neale

September 30, 2021

News Daily News

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

Todd Neale

September 21, 2021

News Daily News

Higher Physical Activity Linked With CAC Progression

Yael L. Maxwell

September 21, 2021

News Daily News

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

Caitlin E. Cox

July 14, 2021

News Daily News

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

Caitlin E. Cox

July 06, 2021

News Daily News

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

L.A. McKeown

June 18, 2021

News Daily News

FDA: Another Class I Recall for HeartWare VAD

Shelley Wood

April 16, 2021

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Daily News

Short-term Mechanical Circulatory Support: Take the Long View

Caitlin E. Cox

March 01, 2021

News Daily News

FDA: Class I Recall for HeartWare VAD Pump Implant Kit

Shelley Wood

March 01, 2021

News Daily News

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Michael O'Riordan

February 10, 2021

Advertisement

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

TCTMD’s Top 10 Most Popular Stories for November 2021

TAVI Is Broadening the Treatable AS Population, Not Cutting Into SAVR

Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs

Higher Physical Activity Linked With CAC Progression

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

AHA Advice for Rare but Deadly Mechanical Complications of Acute MI

FDA: Another Class I Recall for HeartWare VAD

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Short-term Mechanical Circulatory Support: Take the Long View

FDA: Class I Recall for HeartWare VAD Pump Implant Kit

Safe to Upgrade From Pacemaker or Defibrillator to CRT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content